Liquid Biopsy Market Size, Share and Forecast to 2035
The global Liquid Biopsy market was valued at USD 6.20 Billion in 2025, and is projected to reach USD 18.43 Billion by 2035, registering a CAGR of 11.5%. Growth is driven by rising cancer incidence globally, increasing adoption of non-invasive diagnostic techniques, rapid advancements in genomic sequencing technologies, and expanding use of liquid biopsy in early cancer detection and treatment monitoring. Additionally, regulatory support for precision medicine and growing investments in oncology diagnostics are accelerating clinical adoption across healthcare systems.
